Skip to main content
. 2016 Jan 13;115(3):1446–1457. doi: 10.1152/jn.00283.2015

Fig. 7.

Fig. 7.

NO's effects on fictive locomotor occurrence at pro-metamorphic stages are mediated in the brain stem (BS). A: schematic of the recording set up for split-bath experiments (adapted from Clemens et al. 2012). B: VR (VR R20) recording from a stage 54 tadpole showing spontaneous locomotor activity expression during CNS region-specific application of the NO donor SNAP (200 μM). C: pooled data for the mean duration of locomotor activity relative to control (0%) during and after application of NO donors SNAP (200 μM) or DEA-NO (50–200 μM) to the spinal cord (SC) alone (left bar graphs) or the BS alone (right bar graphs) (n = 8). D: same pooled analyses as in C, but for the location-specific co-application of l-NAME and PTIO to either the SC (left; n = 6) or the BS (right; n = 5). Values are means ± SE. *P < 0.05.